JP2005179285A - ヒスタミン遊離抑制剤及びそれを含む飲食品 - Google Patents
ヒスタミン遊離抑制剤及びそれを含む飲食品 Download PDFInfo
- Publication number
- JP2005179285A JP2005179285A JP2003423930A JP2003423930A JP2005179285A JP 2005179285 A JP2005179285 A JP 2005179285A JP 2003423930 A JP2003423930 A JP 2003423930A JP 2003423930 A JP2003423930 A JP 2003423930A JP 2005179285 A JP2005179285 A JP 2005179285A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- histamine release
- walnut
- extracts
- histamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 9
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title abstract description 80
- 229960001340 histamine Drugs 0.000 title abstract description 40
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 27
- 235000020234 walnut Nutrition 0.000 claims abstract description 26
- 244000294611 Punica granatum Species 0.000 claims abstract description 13
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 13
- 241000758789 Juglans Species 0.000 claims abstract description 10
- 239000000419 plant extract Substances 0.000 claims abstract description 7
- 241000758796 Pterocarya rhoifolia Species 0.000 claims abstract description 6
- 241001184553 Thymus x citriodorus Species 0.000 claims abstract description 6
- 244000215554 Nepeta hederacea Species 0.000 claims abstract description 5
- 235000011755 Nepeta hederacea Nutrition 0.000 claims abstract description 5
- 235000007315 Satureja hortensis Nutrition 0.000 claims abstract description 5
- 240000002114 Satureja hortensis Species 0.000 claims abstract description 5
- 229940119155 Histamine release inhibitor Drugs 0.000 claims description 21
- 239000003301 histamine release inhibitor Substances 0.000 claims description 21
- 235000017715 Thymus pulegioides Nutrition 0.000 claims description 12
- 240000006001 Thymus serpyllum Species 0.000 claims description 12
- 235000004054 Thymus serpyllum Nutrition 0.000 claims description 12
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 6
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 6
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 6
- 235000011511 Diospyros Nutrition 0.000 claims description 4
- 244000236655 Diospyros kaki Species 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 241001222097 Xenocypris argentea Species 0.000 claims description 3
- 235000014121 butter Nutrition 0.000 claims description 2
- 239000000284 extract Substances 0.000 abstract description 107
- 235000013399 edible fruits Nutrition 0.000 abstract description 16
- 241000196324 Embryophyta Species 0.000 abstract description 12
- 239000010903 husk Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 33
- 235000013740 Juglans nigra Nutrition 0.000 description 29
- 244000184861 Juglans nigra Species 0.000 description 29
- 230000002401 inhibitory effect Effects 0.000 description 27
- 240000007049 Juglans regia Species 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 235000009508 confectionery Nutrition 0.000 description 16
- 238000000605 extraction Methods 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 241000237502 Ostreidae Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 235000015218 chewing gum Nutrition 0.000 description 8
- 235000020636 oyster Nutrition 0.000 description 8
- 210000003630 histaminocyte Anatomy 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 244000299461 Theobroma cacao Species 0.000 description 6
- 229940112822 chewing gum Drugs 0.000 description 6
- -1 inhalant Substances 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 241000758791 Juglandaceae Species 0.000 description 5
- 239000000739 antihistaminic agent Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 235000015895 biscuits Nutrition 0.000 description 5
- 235000019219 chocolate Nutrition 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003889 eye drop Substances 0.000 description 5
- 235000015243 ice cream Nutrition 0.000 description 5
- 235000015110 jellies Nutrition 0.000 description 5
- 239000008274 jelly Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000003266 anti-allergic effect Effects 0.000 description 4
- 229940125715 antihistaminic agent Drugs 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229940012356 eye drops Drugs 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000007923 nasal drop Substances 0.000 description 4
- 229940109529 pomegranate extract Drugs 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000001369 Juglans ailantifolia Species 0.000 description 3
- 235000000383 Juglans ailantifolia var cordiformis Nutrition 0.000 description 3
- 235000014075 Juglans mandschurica Nutrition 0.000 description 3
- 244000264601 Juglans mandschurica Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010039085 Rhinitis allergic Diseases 0.000 description 3
- 201000010105 allergic rhinitis Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229940100662 nasal drops Drugs 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 235000014046 Juglans ailantifolia Nutrition 0.000 description 2
- 244000049364 Juglans ailantifolia var. cordiformis Species 0.000 description 2
- 240000001439 Opuntia Species 0.000 description 2
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 235000014443 Pyrus communis Nutrition 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 201000009961 allergic asthma Diseases 0.000 description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000024998 atopic conjunctivitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 229920002055 compound 48/80 Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 235000015205 orange juice Nutrition 0.000 description 2
- 235000020737 peppermint extract Nutrition 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000008728 vascular permeability Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- YTFAANNRKOWUTI-UHFFFAOYSA-N CCCCCCCCCC(CCCCCC)OC(=O)CCCCC(O)=O Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)CCCCC(O)=O YTFAANNRKOWUTI-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 235000014056 Juglans cinerea Nutrition 0.000 description 1
- 240000004929 Juglans cinerea Species 0.000 description 1
- 235000000052 Juglans sieboldiana Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- NTCYWJCEOILKNG-ROLPUNSJSA-N [(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]-dimethylazanium;chloride Chemical compound Cl.CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 NTCYWJCEOILKNG-ROLPUNSJSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940073563 dl- methylephedrine hydrochloride Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000001121 post-column derivatisation Methods 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000033398 smooth muscle atrophy Effects 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【解決手段】ザクロ(Punica granatum)、カキドオシ(Glechoma hederacea)、キダチハッカ(Satureja hortensis)、レモンタイム(Thymus citriodorus)、サワグルミ(Pterocarya rhoifolia Sieb.et Zucc)、クルミ科クルミ属(Juglandaceae Juglans)(但し、果実の堅果皮「胡桃殻」部を除く)からなる群より選択される1種又は2種以上の植物抽出物を有効成分とする。
【選択図】なし
Description
、サワグルミ(Pterocarya rhoifolia Sieb.et Zucc)、クルミ科クルミ属(Juglandaceae Juglans)(但し、果実の堅果皮「胡桃殻」部を除く)の抽出物に肥満細胞からのヒスタミン遊離抑制作用に基づく抗アレルギー作用を有することを見い出し、本発明を完成させるに至った。
(Makino)Kitamura)、バタグルミ(Juglans cinerea L)、マンシュウグルミ(Juglans mandshurica Maxim. var. mandshurica)を使用することが好ましい。
但し、S:試料と刺激剤とを添加したときのヒスタミン遊離量、C:刺激剤を添加したときのヒスタミン遊離量、B:試料および刺激剤の双方を添加しないときのヒスタミン遊離量
それぞれの試料の各濃度におけるヒスタミン遊離抑制率を表1に示した。
D−マンニトール 42.6%
乳糖 42.6
結晶セルロース 8.5
ヒドロキシプロピルセルロース 4.3
実施例6のペルシャグルミ抽出物 2.0
100.0%
乳糖 62.5%
馬鈴薯でんぷん 25.0
実施例9のブラックウォールナッツ抽出物 12.5
100.0%
クロロブタノール 0.5g
塩化ナトリウム 0.9
実施例9のオニグルミ抽出物 0.1
注射用水 適量
100.0ml
ミツロウ 3.0%
水素添加ラノリン 8.0
スクワラン 34.0
固形パラフィン 2.0
マイクロクリスタリンワックス 9.0
白色ワセリン 5.0
アジピン酸ヘキシルデシル 13.0
セスキオレイン酸ソルビタン 3.5
ポリオキシエチレン(50)硬化ヒマシ油 1.0
グリセリン 10.0
エタノール 1.0
実施例1のレモンタイム抽出物 0.5
水 10.0
100.0%
エタノール 5.0%
実施例1のカキドオシ抽出物 0.5
実施例3のブラックウォールナッツ抽出物 0.5
水 94.0
100.0%
塩酸ピリドキシン 0.1g
ホウ酸 0.1
塩化ナトリウム 0.6
1N水酸化ナトリウム 適量
実施例8のブラックウォールナッツ抽出物 0.01
水 適量
100.0ml
(pH6.5)
サリチル酸メチル 0.03g
マレイン酸クロルフェニラミン 0.3
dl―塩酸メチルエフェドリン 0.3
ポリソルベート80 0.2
塩化ベンザルコニウム 0.01
塩化ナトリウム 0.6
1N水酸化ナトリウム 適量
実施例5のペルシャグルミ抽出物 1.0
水 適量
100.0ml
(pH6.5)
ガムベース 20.0%
砂糖 54.7
グルコース 15.0
水飴 9.3
香料 0.5
実施例9のペルシャグルミ抽出物 0.5
100.0%
ガムベース 20.0%
砂糖 55.5
グルコース 10.0
水飴 13.0
香料 0.5
実施例5のブラックウォールナッツ抽出物 1.0
100.0%
砂糖 50.0%
水飴 34.0
クエン酸 1.0
香料 0.2
実施例5のテウチグルミ抽出物 0.4
水 14.4
100.0%
砂糖 38.0%
水飴 42.0
クエン酸 1.0
香料 0.2
実施例9のバタグルミ抽出物 0.4
水 18.4
100.0%
カカオビター 20.0%
全脂粉乳 20.0
カカオバター 17.0
粉糖 41.85
レシチン 0.45
香料 0.1
実施例7のブラックウォールナッツ抽出物 0.6
100.0%
砂糖 31.7%
小麦粉 26.8
片栗粉 26.8
バター 3.2
卵 10.7
重曹 0.3
実施例9のマンシュウグルミ抽出物 0.5
100.0%
ポリデキストロース水溶液 40.0%
ソルビトール水溶液 8.0
パラチノース水溶液 9.0
マルトース水溶液 20.0
トレハロース水溶液 11.0
ゼラチン 10.0
酒石酸 1.0
実施例9のヒメグルミ抽出物 1.0
100.0%
砂糖 76.1%
グルコース 19.0
ショ糖脂肪酸エステル 0.2
香料 0.2
実施例1のザクロ抽出物 0.5
水 4.0
100.0%
砂糖 75.7%
乳糖 18.9
ショ糖脂肪酸エステル 0.15
実施例1のキダチハッカ抽出物 1.0
水 4.25
100.0%
卵黄 11.0%
砂糖 14.0
牛乳 37.0
生クリーム 37.0
バニラビーンズ 0.5
実施例3のオニグルミ抽出物 0.5
100.0%
オレンジ果汁 16.0%
砂糖 32.0
実施例9のサワグルミ抽出物 2.0
水 50.0
100.0%
オレンジ果汁 30.0%
異性化糖 15.24
クエン酸 0.1
ビタミンC 0.04
香料 0.1
実施例4のブラックウォールナッツ抽出物 0.1
水 54.42
100.0%
Claims (2)
- ザクロ(Punica granatum)、カキドオシ(Glechoma hederacea)、キダチハッカ(Satureja hortensis)、レモンタイム(Thymus citriodorus)、サワグルミ(Pterocarya rhoifolia Sieb.et Zucc)、クルミ科クルミ属(Juglandaceae Juglans)(但し、果実の堅果皮「胡桃殻」部を除く)からなる群より選択される1種又は2種以上の植物抽出物を有効成分とすることを特徴とするヒスタミン遊離抑制剤。
- 請求項1記載のヒスタミン遊離抑制剤を含むことを特徴とする飲食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003423930A JP4491065B2 (ja) | 2003-12-22 | 2003-12-22 | ヒスタミン遊離抑制剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003423930A JP4491065B2 (ja) | 2003-12-22 | 2003-12-22 | ヒスタミン遊離抑制剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009166055A Division JP5048723B2 (ja) | 2009-07-14 | 2009-07-14 | ヒスタミン遊離抑制剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005179285A true JP2005179285A (ja) | 2005-07-07 |
JP4491065B2 JP4491065B2 (ja) | 2010-06-30 |
Family
ID=34784257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003423930A Expired - Fee Related JP4491065B2 (ja) | 2003-12-22 | 2003-12-22 | ヒスタミン遊離抑制剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4491065B2 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007055995A (ja) * | 2005-07-27 | 2007-03-08 | Hidefumi Kojima | 体臭を消去し、病を治癒する為の薬液 |
JP2008031123A (ja) * | 2006-07-31 | 2008-02-14 | Oriza Yuka Kk | 肝保護剤 |
JP2008184383A (ja) * | 2007-01-26 | 2008-08-14 | Oriza Yuka Kk | 高脂血症及び/又は脂肪肝の治療・予防剤 |
FR2944703A1 (fr) * | 2009-04-22 | 2010-10-29 | Clarins Lab | Composition cosmetique anti age |
KR101076219B1 (ko) * | 2008-12-24 | 2011-10-26 | 고려대학교 산학협력단 | 생체 아민 생성 억제용 조성물 |
JP2012031074A (ja) * | 2010-07-29 | 2012-02-16 | Ogawa & Co Ltd | 冷え性および血流改善剤 |
JP2015535822A (ja) * | 2012-09-21 | 2015-12-17 | ネステク ソシエテ アノニム | 植物性フェノール、及び好酸球性食道炎の治療若しくは予防におけるその使用 |
US20160120930A1 (en) * | 2013-06-07 | 2016-05-05 | Nerthus Aps | Composition for enhancing semen quality in a male subject |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62142193A (ja) * | 1986-12-08 | 1987-06-25 | Nippon Shinyaku Co Ltd | 新規なるタンニン |
JPS62142181A (ja) * | 1986-12-08 | 1987-06-25 | Nippon Shinyaku Co Ltd | 新規なるタンニン |
JPH0769912A (ja) * | 1993-08-30 | 1995-03-14 | Pola Chem Ind Inc | 活性酸素消去剤及びこれを含有する組成物 |
JPH09110710A (ja) * | 1995-10-24 | 1997-04-28 | Ichimaru Pharcos Co Ltd | 皮膚外用剤及び浴用剤 |
WO2001072265A1 (fr) * | 2000-03-31 | 2001-10-04 | The Nisshin Oil Mills, Ltd. | Preparation externe pour la peau et agents d'embellissement |
JP2003286178A (ja) * | 2002-03-29 | 2003-10-07 | Cci Corp | ユーカリプトゥス・シトリオドラの水抽出物を有効成分とする抗アレルギー剤およびこれを含有する食品 |
-
2003
- 2003-12-22 JP JP2003423930A patent/JP4491065B2/ja not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62142193A (ja) * | 1986-12-08 | 1987-06-25 | Nippon Shinyaku Co Ltd | 新規なるタンニン |
JPS62142181A (ja) * | 1986-12-08 | 1987-06-25 | Nippon Shinyaku Co Ltd | 新規なるタンニン |
JPH0769912A (ja) * | 1993-08-30 | 1995-03-14 | Pola Chem Ind Inc | 活性酸素消去剤及びこれを含有する組成物 |
JPH09110710A (ja) * | 1995-10-24 | 1997-04-28 | Ichimaru Pharcos Co Ltd | 皮膚外用剤及び浴用剤 |
WO2001072265A1 (fr) * | 2000-03-31 | 2001-10-04 | The Nisshin Oil Mills, Ltd. | Preparation externe pour la peau et agents d'embellissement |
JP2003286178A (ja) * | 2002-03-29 | 2003-10-07 | Cci Corp | ユーカリプトゥス・シトリオドラの水抽出物を有効成分とする抗アレルギー剤およびこれを含有する食品 |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007055995A (ja) * | 2005-07-27 | 2007-03-08 | Hidefumi Kojima | 体臭を消去し、病を治癒する為の薬液 |
JP2008031123A (ja) * | 2006-07-31 | 2008-02-14 | Oriza Yuka Kk | 肝保護剤 |
JP2008184383A (ja) * | 2007-01-26 | 2008-08-14 | Oriza Yuka Kk | 高脂血症及び/又は脂肪肝の治療・予防剤 |
KR101076219B1 (ko) * | 2008-12-24 | 2011-10-26 | 고려대학교 산학협력단 | 생체 아민 생성 억제용 조성물 |
FR2944703A1 (fr) * | 2009-04-22 | 2010-10-29 | Clarins Lab | Composition cosmetique anti age |
JP2012031074A (ja) * | 2010-07-29 | 2012-02-16 | Ogawa & Co Ltd | 冷え性および血流改善剤 |
JP2015535822A (ja) * | 2012-09-21 | 2015-12-17 | ネステク ソシエテ アノニム | 植物性フェノール、及び好酸球性食道炎の治療若しくは予防におけるその使用 |
US10548873B2 (en) | 2012-09-21 | 2020-02-04 | Societe Des Produits Nestle S.A. | Plant phenols and their use in the treatment or prevention of eosinophilic esophagitis |
US11382891B2 (en) | 2012-09-21 | 2022-07-12 | Societe Des Produits Nestle S.A. | Plant phenols and their use in the treatment or prevention of eosinophilic esophagitis |
US20160120930A1 (en) * | 2013-06-07 | 2016-05-05 | Nerthus Aps | Composition for enhancing semen quality in a male subject |
AU2014276836B2 (en) * | 2013-06-07 | 2019-11-21 | Nerthus Aps | Composition for enhancing semen quality in a male subject |
US10772925B2 (en) * | 2013-06-07 | 2020-09-15 | Nerthus Aps | Composition for enhancing semen quality in a male subject |
Also Published As
Publication number | Publication date |
---|---|
JP4491065B2 (ja) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ538971A (en) | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | |
WO2005072684A1 (ja) | マカ抽出物の製造方法 | |
JP2010209051A (ja) | 脂肪吸収抑制剤 | |
TW200930389A (en) | Wolfberries and inflammation | |
US20100111927A1 (en) | Compositions Comprising Actinidia and Methods of Use Thereof | |
JP2008531584A (ja) | マタタビ属を含む組成物およびそれを用いる方法 | |
JPH07274894A (ja) | 胃潰瘍予防飲食品 | |
US20100247638A1 (en) | organoleptically improved dietary fiber composition and a process thereof (teestar) | |
JP4491065B2 (ja) | ヒスタミン遊離抑制剤 | |
KR20160125019A (ko) | 감나무 추출물을 유효성분으로 포함하는 각막 손상의 예방, 개선 또는 치료용 조성물 | |
WO2009093533A1 (ja) | IgE抗体産生抑制剤 | |
KR102119421B1 (ko) | 개오동나무 추출물을 이용한 항알러지용 조성물 | |
KR101681980B1 (ko) | Colona auricaulata 추출물을 포함하는 당뇨합병증의 예방 또는 치료용 조성물 | |
JP5048723B2 (ja) | ヒスタミン遊離抑制剤 | |
JP2018083764A (ja) | ハマアザミ抽出物を含有する免疫調節用組成物 | |
JP4534003B2 (ja) | 抗アレルギー作用を有する健康食品 | |
JP2001322934A (ja) | 抗酸化作用を有する羅漢果配糖体を含有する抗酸化組成物 | |
KR20160090662A (ko) | 쥐눈이콩 추출물을 포함하는 망막질환의 예방 또는 치료용 조성물 | |
JP2005089374A (ja) | 血糖値上昇抑制機能性飲食品 | |
JP2005022994A (ja) | 血糖上昇抑制用組成物 | |
JP2000086526A (ja) | 免疫賦活剤およびそれを含有する飲食物 | |
KR20170023055A (ko) | 쥐눈이콩 추출물을 포함하는 망막질환의 예방 또는 치료용 조성물 | |
KR102171987B1 (ko) | 나도하수오 추출물을 이용한 항알러지 개선용 조성물 | |
KR100887234B1 (ko) | 상황버섯 추출물을 포함하는 당뇨병 합병증 치료 또는예방용 조성물 | |
KR102114674B1 (ko) | 네튬 마크로스타키움 추출물을 이용한 항알러지용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050912 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20070622 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070628 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090520 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090714 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091113 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100105 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100212 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100319 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100403 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130409 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4491065 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160409 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |